UiPath Shares Slip 1% with $9.4 Billion Valuation Ahead of September 3 Results

UiPath Shares Slip 1% with $9.4 Billion Valuation Ahead of September 3 Results

NEW YORK, August 29, 2026, 19:36 EDT

  • UiPath ended Friday at $18.15, falling 0.98%, with 53.13 million shares changing hands.
  • Fiscal Q2 results will be released after the market closes on September 3.
  • Management forecast revenue in the range of $395 million to $400 million and ARR between $1.929 billion and $1.934 billion.
  • The shares are valued at nearly 4.9 times their projected ARR and approximately 30 times past earnings.

Shares of UiPath fell ahead of its quarterly earnings, which will need to confirm expectations for a strong rebound by 2026. The stock finished the session 8.5% under its 52-week peak, following a surge of almost 100% from its lowest level.

Stock chart for NYSE:PATH

UiPath, Inc. (NYSE: PATH) slipped 0.98% to close at $18.15 on Friday. Trading volume stood at 53.13 million shares, coming in under its latest average MarketWatch quote.

Thursday brings the next test, as UiPath is set to release its fiscal second-quarter results following the market close and plans to hold a webcast at 5 p.m. EDT company announcement.

Management projects revenue between $395 million and $400 million. The midpoint represents a 5% decline from first-quarter sales, due to typical seasonal trends and a tough year-ago comparison.

The company projects annual recurring revenue in the range of $1.929 billion to $1.934 billion. The midpoint suggests net new ARR of approximately $30 million for the quarter.

Investor measureLatest / guidanceRead-through
Friday close$18.158.5% under 52-week peak
Market value$9.40 billionRoughly 4.9× projected Q2 ARR
Q2 revenue guidance$395M–$400MMidpoint tracks 5% under Q1
Q2 ARR guidance$1.929B–$1.934BSequential increase of about $30M
Q2 non-GAAP operating incomeAbout $75MApproximately 19% of sales

UiPath began the quarter with improved operating leverage. Revenue for the first quarter climbed 17% to $418 million. Annualized recurring revenue grew 12% to $1.901 billion first-quarter release.

The company reported its first profitable fiscal first quarter, posting GAAP operating income of $28 million. Adjusted free cash flow was $130 million.

Cash and marketable securities totaled $1.42 billion, providing resources for product investment and a $500 million buyback programme without requiring debt.

The primary issue under discussion is the quality of growth. Dollar-based net retention reached 109%, reflecting ongoing expansion among current customers, though this increase was slower than in previous automation cycles.

Agentic software presents promising potential. UiPath has introduced Maestro Flow, a tool developed to coordinate coding agents throughout enterprise workflows product announcement.

The current valuation reflects expectations that recent product launches will sustain recurring growth. On Friday, the equity value stood at $9.40 billion, or about 4.9 times the midpoint of projected ARR.

Risks: Softer ARR growth may reignite concerns that generative AI could turn automation into a commodity. Postponed enterprise spending and reduced retention rates could weigh on the valuation multiple. Conversely, robust performance might prompt investors to take profits following the 97% bounce from the 52-week low.

Thursday’s report must deliver more than just an earnings beat. Investors will focus on net new ARR, retention rates, and proof that agentic tools are advancing from pilot stages to full-scale production.

UiPath · Earnings setup

NYSE: PATH · fiscal Q2 2027 preview

Updated Aug. 29, 2026 · 19:36 EDT
Friday close$18.15−0.98%
Volume53.13M79% of 65-day average
Market cap$9.40B29.95× trailing earnings
Next catalystSep. 3Results after close

Guidance versus latest quarter

MetricQ1 actualQ2 guideChange
Revenue$418M$395M–$400M−5% midpoint
ARR$1.901B$1.929B–$1.934B+$30M midpoint
Non-GAAP op. income$92M~$75M−18%
GAAP gross margin82%Watch

Valuation bridge

Equity value / guided Q2 ARR

4.87×

Price sits 8.5% below the $19.84 52-week high and 97% above the $9.20 low.

Cash + securities$1.42B
Repurchase authorization$500M
Q1 adjusted FCF$130M

What investors need on September 3

ARR additionAt least the guided $28M–$33M sequential increase.
RetentionEvidence the 109% net retention rate is stabilizing.
Agentic demandProduction deployments, not just pilots, for Maestro and coding-agent tools.

Market data: Aug. 28, 2026, 16:00 EDT. Company guidance: May 28, 2026. Sources: UiPath investor relations; MarketWatch/FactSet; Google Finance.

Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments across global markets. He worked in investment research and market analysis before becoming a financial journalist and is a graduate of the Lahore University of Management Sciences (LUMS).

Tenon Medical Shares Edge Down 0.4% as $3 Million Placement Raises Dilution Risk
Previous Story

Tenon Medical Shares Edge Down 0.4% as $3 Million Placement Raises Dilution Risk

PayPal Stock Sinks 12.7% as $53 Billion Bid Disappears and Turnaround Takes Over
Next Story

PayPal Stock Sinks 12.7% as $53 Billion Bid Disappears and Turnaround Takes Over